<DOC>
	<DOCNO>NCT01617460</DOCNO>
	<brief_summary>The objective study investigate safety efficacy aripiprazole orally administer long term subject complete short-term treatment study pediatric Autistic Disorder ( 031-11-002 study ) .</brief_summary>
	<brief_title>A Long-term , Extended Treatment Study Aripiprazole Pediatric Patients With Autistic Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Autistic Disorder</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>The patient meet Autistic disorder diagnostic criterion define DSMIVTR . The patient complete 03111002 study ( patient visit hospital week8 ) Inpatient outpatient status The patient currently diagnose another disorder autism spectrum DSMIVTR , include Asperger 's , Rett 's Disorder , PDDNOS , Childhood Disintegrative Disorder , FragileX Syndrome . Patients fall contraindication list ABILIFY package insert Others</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Autistic Disorder , child adolescent</keyword>
	<keyword>aripiprazole</keyword>
	<keyword>Long-term safety study</keyword>
	<keyword>child adolescent</keyword>
</DOC>